Cholera Toxin B Subunit as an Immunomodulator for Mucosal Vaccine Delivery
- 1 January 1999
- book chapter
- Published by Elsevier
- Vol. 41, 105-114
- https://doi.org/10.1016/s0065-3519(99)80011-1
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunityProceedings of the National Academy of Sciences, 1997
- Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune systemImmunologic Research, 1997
- Construction and oral immunogenicity of a Salmonella typhimurium strain expressing a streptococcal adhesin linked to the subunits of cholera toxinVaccine, 1996
- Epithelial M Cells: Gateways for Mucosal Infection and ImmunizationCell, 1996
- Induction of antibody‐secreting cells and T‐helper and memory cells in murine nasal lymphoid tissueImmunology, 1996
- Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants.Proceedings of the National Academy of Sciences, 1995
- The Mucosal Adjuvant Activities of ADP-Ribosylating Bacterial EnterotoxinsCritical Reviews in Immunology, 1995
- Cholera toxin and cholera B subunit as oral—mucosal adjuvant and antigen vector systemsVaccine, 1993
- The role of nasopharyngeal lymphoid tissueImmunology Today, 1992
- Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coliNature, 1991